Suggestions
Paulo A. Garcia, Ph.D.
Entrepreneur | Innovator | Company Builder | Life Science Executive | CEO | Board Director | President | Mentor
Paulo A. Garcia, Ph.D., is a prominent scientist and entrepreneur currently serving as the CEO, President, and Board Director at BLASTID, Inc. Based in Cambridge, Massachusetts, he has a robust background in biotechnology and healthcare, with a focus on developing innovative solutions for cell engineering and genetic transformation.
Professional Background
-
Current Position: CEO, President, & Board Director at BLASTID, Inc. He recently transitioned into this role, showcasing his commitment to advancing biotechnological applications.12
-
Previous Experience:
- Co-Founder & CEO of Kytopen (2017 - 2023), where he led the development of a high-throughput cell engineering platform aimed at enhancing the accessibility of living medicines.1
- Research Scientist at the Massachusetts Institute of Technology (MIT), where he contributed to optimizing platforms for genetic engineering and synthetic biology.1
- He has also held various research and academic positions at Virginia Tech and MIT, focusing on innovative medical treatments and technologies.1
Education
Dr. Garcia earned his Ph.D. from Virginia Polytechnic Institute and State University, where he conducted significant research on irreversible electroporation as a minimally invasive treatment for brain tumors.1
Skills and Languages
He is proficient in both English and Spanish, which complements his work in diverse environments and enhances his communication with international partners in the biotech field.1
Dr. Garcia's combination of scientific expertise and entrepreneurial spirit positions him as a key figure in the biotechnology sector, particularly in the development of scalable solutions for cell therapy and genetic engineering.
Highlights
I’m happy to share that I’m starting a new position as CEO, President, & Board Director at BLASTID, Inc!
Honored and thrilled to join the Harvard start-up BLASTID, Inc as the incoming CEO, President, and Board Director. At BLASTID we are translating breakthrough innovations designed and led by our Co-Founder Dr. Johan Paulsson to transform the clinical diagnosis and treatment of bacterial infections (a leading cause of death worldwide). Beyond excited to partner with an industry pioneer Rahul Dhanda as a Co-Founder and Board Chair to further develop and commercialize these innovative technologies. I am grateful to have the opportunity to learn from and work with Eleftherios Mylonakis, an infectious disease ARPA-H DARTS clinical leader, in a collaboration to help demonstrate our patient benefit in a hospital setting. Energized to advance our active and future collaborations towards achieving meaningful global patient impact by tackling the unfolding crisis of antibiotic resistance as part of the largest grant ever received by Harvard (https://lnkd.in/euVX5DMx). #innovation #spinout #partnerships #diagnostics #IVD #portalinnovations
